Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Danske Bank in connection with a SEK 750 million credit facility for Svenska Retursystem
Mandate

Vinge has advised Danske Bank in connection with a SEK 750 million credit facility for Svenska Retursystem

February 16, 2023 Banking and Finance

Vinge has advised Danske Bank A/S, Danmark, Sverige Filial in connection with the signing of a new SEK 750 million credit facility for Svenska Retursystem Aktiebolag.

The credit facility has a tenor of three years with built-in extension options and the parties intend to set certain KPIs whereby the interest rate of the credit facility will be conditional on the company’s achievement of certain set sustainability based targets. The funds shall be used to, inter alia, refinance existing debt and for general corporate and working capital purposes.

Svenska Retursystem’s circular system enables food producers, wholesalers, shops and restaurants to work together to optimise the food industry's supply chain.

Vinge’s team consisted of Albert Wållgren, Arvid Weimers and Karl-Gustaw Tobola.

 

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025